Korean J Anesthesiol.  2003 Oct;45(4):433-436. 10.4097/kjae.2003.45.4.433.

Comparison of Bispectral Index at Each Thiopental Sodium Induction Dose

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Hallym University College of Medicine, Seoul, Korea. kmshin1@yahoo.co.kr

Abstract

BACKGROUND: Thiopental sodium is one of the most commonly used intravenous anesthetics, but there exists no reliable report of BIS that can predict the hypnotic state. Our purpose was to compare BIS values after administering different doses of thiopental sodium.
METHODS
With institutional review board approval and informed consent, sixty adult patients scheduled for elective surgery were studied. The patients were divided into three groups according to induction doses as follows: group 1: 3 mg/kg, group 2: 4 mg/kg, group 3: 5 mg/kg. After induction the BIS was monitored at 15 second intervals to 90 seconds. The number of patients with a BIS of less than 55 was recorded.
RESULTS
The BIS at baseline and 15 seconds after administration were not statistically different in the three groups. The BIS at 30 seconds in group 1 differed from those of groups 2 and 3, but all of the mean BIS values were more than 55. The BIS values at 45 and 90 seconds were statistically different for three groups, and the mean BIS values of groups 2 and 3 were less than 55. The number of patients with a BIS of less than 55 at any point was eight in group 1, and twenty in groups 2 and 3.
CONCLUSIONS
BIS monitoring suggests that a dosage above 4 mg/kg of thiopental sodium is sufficient for the reliable induction of anesthesia.

Keyword

anesthetics; induction; thiopental sodium; bispectral index

MeSH Terms

Adult
Anesthesia
Anesthetics
Anesthetics, Intravenous
Ethics Committees, Research
Humans
Informed Consent
Thiopental*
Anesthetics
Anesthetics, Intravenous
Thiopental
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr